Quick Answer
Armata Pharmaceuticals, Inc. reported Net Income of -$173.80 million for fiscal year 2025.
Armata Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$173.80M | -818.8% |
| 2024 | -$18.92M | +72.6% |
| 2023 | -$69.05M | -87.0% |
| 2022 | -$36.92M | -59.4% |
| 2021 | -$23.16M | -4.4% |
| 2020 | -$22.18M | -13.9% |
| 2019 | -$19.48M | -16.6% |
| 2018 | -$16.70M | -30.1% |
| 2017 | -$12.84M | +31.9% |
| 2016 | -$18.84M | -3550.8% |
| 2015 | -$516.0K | -102.2% |
| 2014 | $23.11M | +135.8% |
| 2013 | -$64.58M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$26.68M | -386.7% | -63.7% |
| June 30, 2025 | -$16.30M | -281.3% | -149.5% |
| March 31, 2025 | -$6.53M | +73.9% | -19.2% |
| September 30, 2024 | -$5.48M | +82.4% | -161.0% |
| June 30, 2024 | $8.99M | +353.3% | +135.9% |
| March 31, 2024 | -$25.02M | -72.7% | +19.7% |
| September 30, 2023 | -$31.16M | -261.7% | -778.5% |
| June 30, 2023 | -$3.55M | +61.5% | +75.5% |
- Armata Pharmaceuticals, Inc. showed a decrease of -818.8% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, Armata Pharmaceuticals, Inc.’s net income has declined by 169.1% (from -$64.58 million to -$173.80 million).
- The most recent figure is from Armata Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: